The current status and future of ADC therapy for small cell Lung Cancer: a promising approach

por Zhou, Jiawei, Ma, Peiwen, Tang, Qiyu, Wang, Shuhang, Li, Ning
Publicado 2023

Seven-year exclusivity and beyond for drugs of rare diseases in China

por Jiang, Yale, Huang, Huiyao, Zhao, Guo, Ma, Peiwen, Zhang, Liang, Wang, Shuhang, Li, Ning
Publicado 2023

CAR-macrophage: An extensive immune enhancer to fight cancer

por Wang, Shuhang, Yang, Yuqi, Ma, Peiwen, Zha, Yan, Zhang, Jin, Lei, Anhua, Li, Ning
Publicado 2022

Evolution of Early-Phase Anticancer Drug Investigations in China

por Wang, Shuhang, Yu, Yue, Jiang, Yale, Zhang, Huishan, Ma, Peiwen, Liu, Gang, Li, Ning
Publicado 2022

Circulating Myeloid Derived Suppressor Cells (MDSC) That Accumulate in Premalignancy Share Phenotypic and Functional Characteristics With MDSC in Cancer

por Ma, Peiwen, Beatty, Pamela L., McKolanis, John, Brand, Randal, Schoen, Robert E., Finn, Olivera J.
Publicado 2019

Clinical Investigations of CAR-T Cell Therapy for Solid Tumors

por Chen, Kun, Wang, Shuhang, Qi, Dan, Ma, Peiwen, Fang, Yuan, Jiang, Ning, Wu, Erxi, Li, Ning
Publicado 2022

Spatial Tuning of Light–Matter Interaction via Strain-Gradient-Induced Polarization in Freestanding Wrinkled 2D Materials

por Cho, Chullhee, Zhang, Zhichao, Kim, Jin Myung, Ma, Peiwen J., Haque, Md Farhadul, Snapp, Peter, Nam, SungWoo
Publicado 2023

Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors

por Wang, Shuhang, Sun, Jingwei, Chen, Kun, Ma, Peiwen, Lei, Qi, Xing, Shujun, Cao, Zhongzheng, Sun, Shujun, Yu, Zicheng, Liu, Yarong, Li, Ning
Publicado 2021

The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials

por Wu, Dawei, Huang, Huiyao, Zhang, Minghui, Li, Ziwei, Wang, Shuhang, Yu, Yue, Fang, Yuan, Jiang, Ning, Miao, Huilei, Ma, Peiwen, Tang, Yu, Li, Ning
Publicado 2022

Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials

por Wang, Shuhang, Yang, Yuqi, Ma, Peiwen, Huang, Huiyao, Tang, Qiyu, Miao, Huilei, Fang, Yuan, Jiang, Ning, Li, Yandong, Zhu, Qi, Tao, Wei, Zha, Yan, Li, Ning
Publicado 2022

KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese Patients

por Wang, Shuhang, Li, Qin, Ma, Peiwen, Fang, Yuan, Yu, Yue, Jiang, Ning, Miao, Huilei, Tang, Qiyu, Yang, Yuqi, Xing, Shujun, Chen, Rongrong, Yi, Xin, Li, Ning
Publicado 2022

Association between germ-line HLA and immune-related adverse events

por Jiang, Ning, Yu, Yue, Zhang, Min, Tang, Yu, Wu, Dawei, Wang, Shuhang, Fang, Yuan, Zhang, Yu, Meng, Lin, Li, Yingying, Miao, Huilei, Ma, Peiwen, Huang, Huiyao, Li, Ning
Publicado 2022

Identification of Tumor Antigens and Immune Subtypes of Malignant Mesothelioma for mRNA Vaccine Development

por Wang, Shuhang, Yang, Yuqi, Li, Lu, Ma, Peiwen, Jiang, Yale, Ge, Minghui, Yu, Yue, Huang, Huiyao, Fang, Yuan, Jiang, Ning, Miao, Huilei, Guo, Hao, Yan, Linlin, Ren, Yong, Sun, Lichao, Zha, Yan, Li, Ning
Publicado 2022

Targeting rare tumors: new focus for clinical research in China

por Wang, Shuhang, Jiang, Yale, Miao, Huilei, Fang, Yuan, Jiang, Ning, Yu, Yue, Ma, Peiwen, Tang, Qiyu, Cui, Dandan, Fang, Hong, Huang, Huiyao, Fan, Qi, Sun, Chao, Yu, Anqi, Miao, Shuangman, Du, Jingting, Zhu, Jingxiao, Wang, Yuning, Li, Ning
Publicado 2022

The state of the art of bispecific antibodies for treating human malignancies

por Wang, Shuhang, Chen, Kun, Lei, Qi, Ma, Peiwen, Yuan, Andy Qingan, Zhao, Yong, Jiang, Youwei, Fang, Hong, Xing, Shujun, Fang, Yuan, Jiang, Ning, Miao, Huilei, Zhang, Minghui, Sun, Shujun, Yu, Zicheng, Tao, Wei, Zhu, Qi, Nie, Yingjie, Li, Ning
Publicado 2021

The reliability and integrity of overall survival data based on follow-up records only and potential solutions to the challenges

por Huang, Huiyao, Tang, Yu, Yu, Yue, Yu, Anqi, Wu, Dawei, Fang, Hong, Wang, Shuhang, Sun, Chao, Wang, Xin, Fan, Qi, Fang, Yuan, Tang, Qiyu, Jiang, Ning, Du, Jingting, Miao, Huilei, Bai, Ying, Ma, Peiwen, Xing, Shujun, Cui, Dandan, Miao, Shuangman, Jiang, Yale, Zhu, Jingxiao, Zhu, Qi, Leng, Ye, Guo, Lan Wei, Liao, Shanmei, Shao, Yaguang, Song, Yinyin, Liu, Zeyuan, Hong, Minghuang, Luo, Suxia, Xu, Binghe, Lan, Gongtao, Li, Ning
Publicado 2022